A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification

Drug and Alcohol Dependence

Volumn 94, Issue 1-3, 2008, Pages 199-206

  Gruber, Valerie A ^a   Delucchi, Kevin L ^a   Kielstein, Anousheh ^b   Batki, Steven L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Dr Kielstein GmbH   (Germany)

Author keywords

Contingency management; Counseling; Methadone maintenance; Opioid dependence

Indexed keywords

ISONIAZID; METHADONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; FEMALE; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL WORK; TUBERCULOSIS;

ADULT; COUNSELING; DEMOGRAPHY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; METHADONE; NARCOTICS; TIME FACTORS;

EID: 39149137200     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.11.021     Document Type: Article

References (29)

1. Amato L., Davoli M., Perucci C.A., Ferri M., Faggiano F., and Mattick R.P. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J. Subst. Abuse Treat. 28 (2005) 321-329 10.1016/j.jsat.2005.02.007
2. Amato L., Davoli M., Minozzi S., Ali R., and Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst. Rev. 3. (2005) 10.1002/14651858.CD004147.pub3 (Art. no.: CD003409.)
3. Amato L., Minozzi S., Davoli M., Vecchi S., Ferri M., and Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst. Rev. 4. (2004) 10.1002/14651858.CD004147.pub2 (Art. no.: CD004147)
4. Batki S.L., Gruber V.A., Bradley J.M., Bradley M., and Delucchi K. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 66 (2002) 283-293 10.1016/S0376-8716(01)00208-3
5. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiat. 4 (1961) 561-571
6. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, 2005. Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol (TIP) Series 43. DHHS Publication No. (SMA) 05-4048. Substance Abuse and Mental Health Services Administration, Rockville, MD, U.S.A.
7. Elk R., Schmitz J., Spiga R., Rhoades H., Andres R., and Grabowski J. Behavioral treatment of cocaine-dependent pregnant women and TB-exposed patients. Addict. Behav. 20 4 (1995) 533-542
8. Faggiano F., Vigna-Taglianti F., Versino E., and Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst. Rev. 3. (2003) 10.1002/14651858.CD002208 (Art. no.: CD002208)
9. Federal Register, Title 21, 1993. Codified at 58 CFR &495, pt 291. U.S.A.
10. Gawin F.H., and Kleber H.D. Cocaine abuse treatment: open pilot trial with desipramine and lithium carbonate. Arch. Gen. Psychiat. 41 (1984) 903-909
11. Mattick R.P., Breen C., Kinber J., and Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst. Rev. 2 (2003) 10.1002/14651858.CD002209 (Art. no.: CD002209)
12. McLellan A.T., Alterman A.I., Cacciola J., Metzger D., and O'Brien C.P. A new measure of substance abuse treatment: initial studies of the treatment services review. J. Nerv. Ment. Dis. 168 (1992) 26-38 10.1016/S0740-5472(03)00106-5
13. McLellan A.T., Arndt I.O., Metzger D.S., Woody G.E., and O'Brien C.P. The effects of psychosocial services in substance abuse treatment. J. Am. Med. Assoc. 269 (1993) 1953-1959
14. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 9 3 (1992) 199-213 10.1016/0740-5472(92)90062-S
15. Miller W.R., and Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed. (2002), Guilford Press, New York
16. Morral A.R., Belding M.A., and Iguchi M.Y. Identifying methadone maintenance clients at risk for poor treatment response: pretreatment and early progress indicators. Drug Alcohol Depend. 55 (1999) 25-33 10.1016/S0376-8716(98)00176-8
17. Newman G., and Whitehill W.B. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet 2 8141 (1979) 485-488
18. National Institute of Health (NIH) Consensus Development Panel. Effective medical treatment of opiate addiction. J. Am. Med. Assoc. 280 (1998) 1936-1943
19. Saxon A.J., Wells E.A., Fleming C., Jackson T.R., and Calsyn D.A. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 91 (1996) 1197-1209
20. Schwartz R.P., Highfield D., Jaffe J.H., Brady J.V., Butler C.B., Rouse C.O., Callaman J.M., O'Grady K.E., and Battjes R.J. A randomized controlled trial of interim methadone maintenance. Arch. Gen. Psychiat. 63 (2006) 102-109
21. Schwartz R.P., Jaffe J.H., Highfield D.A., Callaman J.M., and O'Grady K.E. A randomized controlled trial of interim methadone maintenance: 10-month follow-up. Drug Alcohol Depend. 86 (2007) 30-36 10.1016/j.drugalcdep.2006.04.017
22. Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., Banys P., and Hall S.M. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. J. Am. Med. Assoc. 283 (2000) 1303-1310
23. Solberg U., Burkhart G., and Nilson M. An overview of opiate substitution treatment in the European Union and Norway. Int. J. Drug Policy 13 (2002) 477-484
24. Spitzer R.I., Williams J.B.W., and First M.B. Structured Clinical Interview for DSM-III-R Patient Version (1989), Biometrics Research Department, New York
25. Strain E.C., Bigelow G.E., Liebson I.A., and Stitzer M.L. Moderate- vs. high-dose methadone in the treatment of opioid dependence: a randomized trial. J. Am. Med. Assoc. 281 (1999) 1000-1005
26. Strain E.C., Stitzer M.L., Liebson I.A., and Bigelow G.E. Dose-response effects of methadone in the treatment of opioid dependence. Ann. Internal Med. 119 (1993) 23-27
27. Trafton J.A., Minkel J., and Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. Public Library Sci. Med. 3 (2006) e80 10.1371/journal.pmed.0030080
28. Vanichseni S., Wongsuwan B., Choopanya K., and Wongpanich K. A controlled trial of methadone maintenance in a population of intravenous drug users in Bangkok: implications for prevention of HIV. Int. J. Addict. 26 (1991) 1313-1320
29. Yancovitz S.R., Des Jarlais D.C., Peskoe Peyser N., Drew E., Friedmann P., Trigg H.L., and Robinson J.W. A randomized trial of an interim methadone maintenance clinic. Am. J. Public Health 81 (1991) 1185-1191